Ziprasidone Intramuscular Injection

Form: Intramuscular Injection (IM)

Strength: 20 mg/mL

Reference Brands: Zeldox®(EU); Geodon®(US)

Category: Antipsychotropic Drugs

Ziprasidone intramuscular injection (brand name: Geodon) is FDA-approved in the United States for the acute treatment of agitation in patients with schizophrenia. It is intended for short-term use when rapid control of symptoms is clinically necessary. In the European Union, it is approved under the name Zeldox for similar indications. Regulatory approval requires GMP-compliant injectable manufacturing, validated safety and efficacy data, and pharmacokinetic studies supporting rapid onset. U.S. labeling includes warnings for QT interval prolongation and cardiac risk. EU approvals require Risk Management Plans (RMPs) and ongoing pharmacovigilance. For sourcing and dossier-ready options, visit Pharmatradz.com.